Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
B 9.80 -0.81% -0.08
DXR closed down 0.81 percent on Friday, May 3, 2024, on 1.61 times normal volume.
Earnings due: May 14
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Gapped Down Weakness 0.00%
Pocket Pivot Bullish Swing Setup -0.81%
Volume Surge Other -0.81%
Bollinger Band Squeeze Range Contraction -0.81%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Daxor Corporation Description

Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Disorders Hypertension Heart Failure Hematology Anemia Radiology Blood Transfusion Medicine Red Blood Cell Science Kidney Failure Blood Transfusion Medical Device Manufacturing Blood Volume Hematopathology Polycythemia Syncope

Is DXR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.3
52 Week Low 7.11
Average Volume 3,148
200-Day Moving Average 8.95
50-Day Moving Average 8.84
20-Day Moving Average 9.69
10-Day Moving Average 9.79
Average True Range 0.27
RSI (14) 59.18
ADX 9.9
+DI 24.61
-DI 34.15
Chandelier Exit (Long, 3 ATRs) 9.13
Chandelier Exit (Short, 3 ATRs) 9.38
Upper Bollinger Bands 9.97
Lower Bollinger Band 9.41
Percent B (%b) 0.7
BandWidth 5.81
MACD Line 0.25
MACD Signal Line 0.28
MACD Histogram -0.0336
Fundamentals Value
Market Cap 38.11 Million
Num Shares 3.89 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 184.91
Price-to-Sales 98.79
Price-to-Book 4.99
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.46
Resistance 3 (R3) 10.44 10.19 10.35
Resistance 2 (R2) 10.19 10.03 10.21 10.31
Resistance 1 (R1) 10.00 9.92 10.10 10.02 10.28
Pivot Point 9.75 9.75 9.80 9.77 9.75
Support 1 (S1) 9.56 9.59 9.66 9.58 9.32
Support 2 (S2) 9.31 9.48 9.33 9.29
Support 3 (S3) 9.12 9.31 9.25
Support 4 (S4) 9.14